Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1984 Apr;81(7):2181–2185. doi: 10.1073/pnas.81.7.2181

Thymus-derived lymphocytes and their interactions with macrophages are required for the production of osteoclast-activating factor in the mouse.

M Horowitz, A Vignery, R K Gershon, R Baron
PMCID: PMC345461  PMID: 6609360

Abstract

A bone-resorbing factor, comparable to the osteoclast-activating factor (OAF) produced from peripheral blood leukocytes, is shown to be produced by murine spleen cells activated with the T-cell mitogen Con A. Murine OAF is demonstrated here as being a product of the interaction between thymus-derived T lymphocytes and macrophages. Activation of T cells in the presence of macrophages with Con A yields culture supernatants with OAF activity. This OAF activity is not dialyzable and is not extracted by lipid solvents. Purified B cells in the presence or absence of macrophages and cocultured with Con A or activated with the B-cell-specific mitogen lipopolysaccharide yield culture supernatants with no detectable OAF activity. Similarly, macrophages cocultured with Con A or activated with lipopolysaccharide fail to yield culture supernatants with bone resorbing activity. These types of immune cell interactions are similar to that required for the production of lymphokines. These data support the hypothesis that one aspect of regulation of bone remodeling is through cells of the immune system.

Full text

PDF
2184

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ash P., Loutit J. F., Townsend K. M. Osteoclasts derived from haematopoietic stem cells. Nature. 1980 Feb 14;283(5748):669–670. doi: 10.1038/283669a0. [DOI] [PubMed] [Google Scholar]
  2. Chen P., Trummel C., Horton J., Baker J. J., Oppenheim J. J. Production of osteoclast-activating factor by normal human peripheral blood rosetting and nonrosetting lymphocytes. Eur J Immunol. 1976 Oct;6(10):732–736. doi: 10.1002/eji.1830061014. [DOI] [PubMed] [Google Scholar]
  3. Glode L. M., Scher I., Osborne B., Rosenstreich D. L. Cellular mechanism of endotoxin unresponsiveness in C3H/HeJ mice. J Immunol. 1976 Feb;116(2):454–461. [PubMed] [Google Scholar]
  4. Hausmann E., Weinfeld N., Miller W. A. Effects of lipopolysaccharides on bone resorption in tissue culture. Calcif Tissue Res. 1972;9(4):272–282. doi: 10.1007/BF02061967. [DOI] [PubMed] [Google Scholar]
  5. Horton J. E., Koopman W. J., Farrar J. J., Fuller-Bonar J., Mergenhagen S. E. Partial purification of a bone-resorbing factor elaborated from human allogeneic cultures. Cell Immunol. 1979 Mar 1;43(1):1–10. doi: 10.1016/0008-8749(79)90144-8. [DOI] [PubMed] [Google Scholar]
  6. Horton J. E., Oppenheim J. J., Mergenhagen S. E. A role for cell-mediated immunity in the pathogenesis of periodontal disease. J Periodontol. 1974 May;45(5):351–360. doi: 10.1902/jop.1974.45.5.351. [DOI] [PubMed] [Google Scholar]
  7. Horton J. E., Oppenheim J. J., Mergenhagen S. E., Raisz L. G. Macrophage-lymphocyte synergy in the production of osteoclast activating factor. J Immunol. 1974 Oct;113(4):1278–1287. [PubMed] [Google Scholar]
  8. Horton J. E., Raisz L. G., Simmons H. A., Oppenheim J. J., Mergenhagen S. E. Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes. Science. 1972 Sep 1;177(4051):793–795. doi: 10.1126/science.177.4051.793. [DOI] [PubMed] [Google Scholar]
  9. Kahn A. J., Stewart C. C., Teitelbaum S. L. Contact-mediated bone resorption by human monocytes in vitro. Science. 1978 Mar 3;199(4332):988–990. doi: 10.1126/science.622581. [DOI] [PubMed] [Google Scholar]
  10. Klein D. C., Raisz L. G. Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology. 1970 Jun;86(6):1436–1440. doi: 10.1210/endo-86-6-1436. [DOI] [PubMed] [Google Scholar]
  11. Luben R. A., Mundy G. R., Trummel C. L., Raisz L. G. Partial purification of osteoclast-activating factor from phytohemagglutinin-stimulated human leukocytes. J Clin Invest. 1974 May;53(5):1473–1480. doi: 10.1172/JCI107696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Luben R. A. Purification of a lymphokine: osteoclast activating factor from human tonsil lymphocytes. Biochem Biophys Res Commun. 1978 Sep 14;84(1):15–22. doi: 10.1016/0006-291x(78)90256-5. [DOI] [PubMed] [Google Scholar]
  13. Malone J. D., Teitelbaum S. L., Griffin G. L., Senior R. M., Kahn A. J. Recruitment of osteoclast precursors by purified bone matrix constituents. J Cell Biol. 1982 Jan;92(1):227–230. doi: 10.1083/jcb.92.1.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Marx S. J., Aurbach G. D., Gavin J. R., 3rd, Buell D. W. Calcitonin receptors on cultured human lymphocytes. J Biol Chem. 1974 Nov 10;249(21):6812–6816. [PubMed] [Google Scholar]
  15. Milhaud G., Labat M. L., Graf B., Thillard M. J. Guérison de l'ostéopétrose congénitale du rat "op" par greffe de thymus. C R Acad Sci Hebd Seances Acad Sci D. 1976 Sep 20;283(5):531–533. [PubMed] [Google Scholar]
  16. Milhaud G., Labat M. L., Moricard Y. (Dichloromethylene)diphosphonate-induced impairment of T-lymphocyte function. Proc Natl Acad Sci U S A. 1983 Jul;80(14):4469–4473. doi: 10.1073/pnas.80.14.4469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Milhaud G., Labat M. L. Thymus and osteopetrosis. Clin Orthop Relat Res. 1978 Sep;(135):260–271. [PubMed] [Google Scholar]
  18. Mundy C. R., Altman A. J., Gondek M. D., Bandelin J. G. Direct resorption of bone by human monocytes. Science. 1977 Jun 3;196(4294):1109–1111. doi: 10.1126/science.16343. [DOI] [PubMed] [Google Scholar]
  19. Mundy G. R., Luben R. A., Raisz L. G., Oppenheim J. J., Buell D. N. Bone-resorbing activity in supernatants from lymphoid cell lines. N Engl J Med. 1974 Apr 18;290(16):867–871. doi: 10.1056/NEJM197404182901601. [DOI] [PubMed] [Google Scholar]
  20. Mundy G. R., Raisz L. G., Cooper R. A., Schechter G. P., Salmon S. E. Evidence for the secretion of an osteoclast stimulating factor in myeloma. N Engl J Med. 1974 Nov 14;291(20):1041–1046. doi: 10.1056/NEJM197411142912001. [DOI] [PubMed] [Google Scholar]
  21. Mundy G. R., Raisz L. G., Shapiro J. L., Bandelin J. G., Turcotte R. J. Big and little forms of osteoclast activating factor. J Clin Invest. 1977 Jul;60(1):122–128. doi: 10.1172/JCI108748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Mundy G. R., Rick M. E., Turcotte R., Kowalski M. A. Pathogenesis of hypercalcemia in lymphosarcoma cell leukemia. Role of an osteoclast activating factor-like substance and a mechanism of action for glucocorticoid therapy. Am J Med. 1978 Oct;65(4):600–606. doi: 10.1016/0002-9343(78)90847-1. [DOI] [PubMed] [Google Scholar]
  23. Mundy G. R., Varani J., Orr W., Gondek M. D., Ward P. A. Resorbing bone is chemotactic for monocytes. Nature. 1978 Sep 14;275(5676):132–135. doi: 10.1038/275132a0. [DOI] [PubMed] [Google Scholar]
  24. Nussenzweig M. C., Steinman R. M., Witmer M. D., Gutchinov B. A monoclonal antibody specific for mouse dendritic cells. Proc Natl Acad Sci U S A. 1982 Jan;79(1):161–165. doi: 10.1073/pnas.79.1.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Provvedini D. M., Tsoukas C. D., Deftos L. J., Manolagas S. C. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science. 1983 Sep 16;221(4616):1181–1183. doi: 10.1126/science.6310748. [DOI] [PubMed] [Google Scholar]
  26. Raisz L. G., Niemann I. Effect of phosphate, calcium and magnesium on bone resorption and hormonal responses in tissue culture. Endocrinology. 1969 Sep;85(3):446–452. doi: 10.1210/endo-85-3-446. [DOI] [PubMed] [Google Scholar]
  27. Raisz L. G., Simmons H. A., Gworek S. C., Eilon G. Studies on congenital osteopetrosis in microphthalmic mice using organ cultures: impairment of bone resorption in response to physiologic stimulators. J Exp Med. 1977 Apr 1;145(4):857–865. doi: 10.1084/jem.145.4.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Stewart A. F. Is there a role for parathyroid hormone in humoral hypercalcemia of malignancy? Miner Electrolyte Metab. 1982 Sep-Oct;8(3-4):215–226. [PubMed] [Google Scholar]
  29. Tanaka H., Abe E., Miyaura C., Kuribayashi T., Konno K., Nishii Y., Suda T. 1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). Biochem J. 1982 Jun 15;204(3):713–719. doi: 10.1042/bj2040713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Trummel C. L., Mundy G. R., Raisz L. G. Release of osteoclast activating factor by normal human peripheral blood leukocytes. J Lab Clin Med. 1975 Jun;85(6):1001–1007. [PubMed] [Google Scholar]
  31. Walker D. G. Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells. Science. 1975 Nov 21;190(4216):784–785. doi: 10.1126/science.1105786. [DOI] [PubMed] [Google Scholar]
  32. Walker D. G. Osteopetrosis cured by temporary parabiosis. Science. 1973 May 25;180(4088):875–875. doi: 10.1126/science.180.4088.875. [DOI] [PubMed] [Google Scholar]
  33. Whitfield J. F., MacManus J. P., Rixon R. H. The possible mediation by cyclic AMP of parathyroid hormone-induced stimulation of mitotic activity and deoxyribonucleic acid synthesis in rat thymic lymphocytes. J Cell Physiol. 1970 Apr;75(2):213–224. doi: 10.1002/jcp.1040750210. [DOI] [PubMed] [Google Scholar]
  34. Wysocki L. J., Sato V. L. "Panning" for lymphocytes: a method for cell selection. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2844–2848. doi: 10.1073/pnas.75.6.2844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Yamamoto I., Potts J. T., Jr, Segre G. V. Circulating bovine lymphocytes contain receptors for parathyroid hormone. J Clin Invest. 1983 Feb;71(2):404–407. doi: 10.1172/JCI110784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Yoneda T., Mundy G. R. Monocytes regulate osteoclast-activating factor production by releasing prostaglandins. J Exp Med. 1979 Aug 1;150(2):338–350. doi: 10.1084/jem.150.2.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Yoneda T., Mundy G. R. Prostaglandins are necessary for osteoclast-activating factor production by activated peripheral blood leukocytes. J Exp Med. 1979 Jan 1;149(1):279–283. doi: 10.1084/jem.149.1.279. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES